American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis
Рекомендации Американской коллегии ревматологов 2008 года по применению небиологических и биологических базисных противоревматических препаратов при ревматоидном артрите
2008-05-30
SCID: 54.1/ywwvzqut
Discuss with AI
American College of Rheumatologybiologic DMARDsdisease-modifying antirheumatic drugsnonbiologic DMARDsrheumatoid arthritis
Figures from the paper
Abstract (AI)
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient’s individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice.
Key Findings
1
Application of the recommendations is voluntary and should be determined by physicians according to each patient’s circumstances.
2
The American College of Rheumatology developed recommendations for using nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.
3
The recommendations aim to promote beneficial outcomes but cannot guarantee specific results.
4
The recommendations are subject to periodic revision as medical knowledge, technology, and clinical practice evolve.
5
The recommendations provide guidance for particular clinical practice patterns rather than dictating treatment for individual patients.
Research Object
Use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
Research Subject
ACR 2008 recommendations and practice guidance for drug use, tailored to individual patient circumstances
Publication Details
Publication Date
2008-05-30
Journal
Publisher
ISSN
Access Type
Author Information
Download PDF
Subscribe to digest